Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jan 19;15(3):531.
doi: 10.3390/nu15030531.

Treatment of HMG-CoA Lyase Deficiency-Longitudinal Data on Clinical and Nutritional Management of 10 Australian Cases

Affiliations
Review

Treatment of HMG-CoA Lyase Deficiency-Longitudinal Data on Clinical and Nutritional Management of 10 Australian Cases

Susan Thompson et al. Nutrients. .

Abstract

3-Hydroxy-3-Methylglutaryl-CoA Lyase (HMGCL) deficiency can be a very severe disorder that typically presents with acute metabolic decompensation with features of hypoketotic hypoglycemia, hyperammonemia, and metabolic acidosis. A retrospective chart and literature review of Australian patients over their lifespan, incorporating acute and long-term dietary management, was performed. Data from 10 patients contributed to this study. The index case of this disorder was lost to follow-up, but there is 100% survival in the remainder of the cases despite several having experienced life-threatening episodes. In the acute setting, five of nine patients have used 900 mg/kg/day of sodium D,L 3-hydroxybutyrate in combination with intravenous dextrose-containing fluids (delivering glucose above estimated basal utilization requirements). All patients have been on long-term protein restriction, and those diagnosed more recently have had additional fat restriction. Most patients take L-carnitine. Three children and none of the adults take nocturnal uncooked cornstarch. Of the cohort, there were two patients that presented atypically-one with fulminant liver failure and the other with isolated developmental delay. Dietary management in patients with HMGCL deficiency is well tolerated, and rapid institution of acute supportive metabolic treatment is imperative to optimizing survival and improve outcomes in this disorder.

Keywords: 3 Hydroxybutyrate; HMG Co A Lyase; fat oxidation; hyperammonemia; ketones; leucine oxidation; liver failure; low-fat diet; low-protein diet; metabolic decompensation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Graphical illustration of the various enzymes and metabolites involved in leucine catabolism and ketone body synthesis. HMG-CoA Lyase is the enzyme involved in the final step of mitochondrial ketone body production from both fatty acid oxidation and leucine catabolism. Reduced or absent function of this enzyme causes accumulation of HMG (3-hydroxy-3-methylglutyrate), MGC (3-methylglutaconate), MGL (3-methylglutarate), and 3HIV (3-hydroxyisovalerate) in bodily fluids.

References

    1. Pié J., López-Viñas E., Puisac B., Menao S., Pié A., Casale C., Ramos F.J., Hegardt F.G., Gómez-Puertas P., Casals N. Molecular genetics of HMG-CoA lyase deficiency. Mol. Genet. Metab. 2007;92:198–209. doi: 10.1016/j.ymgme.2007.06.020. - DOI - PubMed
    1. Faull K., Bolton P., Halpern B., Hammond J., Danks D.M., Hähnel R., Wilkinson S.P., Wysocki S.J., Masters P.L. Letter: Patient with defect in leucine metabolism. N. Engl. J. Med. 1976;294:1013. doi: 10.1056/nejm197604292941823. - DOI - PubMed
    1. Wysocki S.J., Hähnel R. 3-hydroxy-3-methylglutaric aciduria: 3-Hydroxy-3-methylglutaryl-coenzyme a lyase levels in leucocytes. Clin. Chim. Acta. 1976;73:373–375. doi: 10.1016/0009-8981(76)90186-8. - DOI - PubMed
    1. Mitchell G.A., Robert M.F., Hruz P.W., Wang S., Fontaine G., Behnke C.E., Mende-Mueller L.M., Schappert K., Lee C., Gibson K.M., et al. 3-Hydroxy-3-methylglutaryl coenzyme A lyase (HL). Cloning of human and chicken liver HL cDNAs and characterization of a mutation causing human HL deficiency. J. Biol. Chem. 1993;268:4376–4381. doi: 10.1016/S0021-9258(18)53620-6. - DOI - PubMed
    1. Grünert S.C., Schlatter S.M., Schmitt R.N., Gemperle-Britschgi C., Mrázová L., Balcı M.C., Bischof F., Çoker M., Das A.M., Demirkol M., et al. 3-Hydroxy-3-methylglutaryl-coenzyme A lyase deficiency: Clinical presentation and outcome in a series of 37 patients. Mol. Genet. Metab. 2017;121:206–215. doi: 10.1016/j.ymgme.2017.05.014. - DOI - PubMed

Supplementary concepts